|

Anti-Obesity Pharmacotherapy (Class Effect) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GLP-1 receptor agonist, Incretin Mimetics, Phentermine, Topiramate

Pipeline

Phase 4: 1

Top Sponsors

  • The Cleveland Clinic1

Indications

  • Severe Obesity1
  • Liver Disease1
  • Portal Hypertension Related to Cirrhosis1
  • Liver Cirrhoses1
  • TIPS1

Cleveland, Ohio1 trial

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Cleveland Clinic Main Campus

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.